1-19814494-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_019062.2(RNF186):c.608G>A(p.Arg203Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000458 in 1,614,138 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R203W) has been classified as Uncertain significance.
Frequency
Consequence
NM_019062.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF186 | NM_019062.2 | c.608G>A | p.Arg203Gln | missense_variant | 1/1 | ENST00000375121.4 | NP_061935.1 | |
RNF186-AS1 | NR_186008.1 | n.86C>T | non_coding_transcript_exon_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF186 | ENST00000375121.4 | c.608G>A | p.Arg203Gln | missense_variant | 1/1 | 6 | NM_019062.2 | ENSP00000364263.2 | ||
RNF186-AS1 | ENST00000454736.1 | n.128C>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152160Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251254Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135830
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461860Hom.: 1 Cov.: 30 AF XY: 0.0000660 AC XY: 48AN XY: 727234
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152278Hom.: 1 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74456
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at